FDA gave its blessing based on a trial showing it offered breast cancer patients an extra 5.5 months of "progression-free survival," time when their tumors weren't growing.
FDA是基于阿瓦斯丁可以让患者的肿瘤在5个半月内都不增长的研究,批准了阿瓦斯丁的使用许可。
In America the Food and Drug Administration gave its blessing in 2005 to clinical trials involving cancer patients, and these too are due to conclude this year.
美国食品药品管理局于2005年向Sativex就包括癌症患者在内的临床试验开了绿灯,并将于今年内取得最终结果。
应用推荐